Orlinger Klaus 4
4 · HOOKIPA Pharma Inc. · Filed Apr 20, 2022
Insider Transaction Report
Form 4
Orlinger Klaus
Sr. VP, Research
Transactions
- Award
Stock Option (Right to Buy)
2022-04-19+48,350→ 48,350 totalExercise: $1.66Exp: 2032-04-19→ Common Stock (48,350 underlying)
Footnotes (1)
- [F1]25% of this option shall vest on April 19, 2023, with the remainder vesting in 12 equal quarterly installments thereafter.